http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Agilent Technologies to Present at J.P. Morgan Healthcare Conference
-
Agilent Ranked Among Top Four Best Workplaces in Greater China and Receives Certification as a Best Workplace for Women in Greater China
-
Agilent Receives Multiple Life Science Industry Awards for Innovation
-
Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results
-
Agilent (A) Companion Diagnostic Expands CE-IVD mark in Europe to include HNSCC
-
Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC)
-
Agilent Announces Applications Open for LabCentral Golden Ticket
-
Agilent Technologies Increases Cash Dividend to 18 Cents Per Share
-
Burning Rock Dx Launches Magnis BR to Innovate Total Process Automation for NGS Testing
-
Agilent Announces New ICP-OES Systems with Innovative Instrument Intelligence
-
Agilent Named One of Top 10 Best Workplaces in Singapore
-
Agilent Technologies to Host Conference Call to Review Fourth Quarter Fiscal Year 2019 Financial Results; Announces Schedule for Upcoming Webcasts
-
CORRECTING and REPLACING Agilent Technologies to Host Conference Call to Review Fourth Quarter Fiscal Year 2019 Financial Results; Announces Schedule for Upcoming Webcasts
-
Agilent Expands Portfolio of Smart-Connected GC Instruments
-
Agilent Early Career Professor Award Presented to Saeed Hassanpour
-
Agilent Opens State-of-the-Art Spectroscopy Site in the UK
-
Agilent Named Industry Leader in 2019 Dow Jones Sustainability Index
-
Agilent Technologies (A) Granted Approval for First PD-L1 Companion Diagnostic in China
-
Agilent Receives Approval for First PD-L1 Companion Diagnostic in China
-
Agilent Presents Thought Leader Award to Professor Hualiang Jiang
-
Agilent Technologies Announces Cash Dividend of 16.4 Cents Per Share
-
Agilent Collaborates on Groundbreaking Study of Performance-Enhancing Spinach Extract
-
Agilent Presents Thought Leader Award to Professor Hyun Joo An
-
Agilent Technologies Releases 2018 Corporate Social Responsibility Report
-
Agilent Completes Acquisition of BioTek Instruments
-
NUS, Agilent, and NUH Launch New Translational R&D Hub to Boost Clinical Diagnostics
-
Agilent OFS Academy Receives Learning!100 Award for Third Consecutive Year
-
Agilent Introduces Revolutionary Real-Time Cell Analyzer
-
Agilent Presents Thought Leader Award to Professor Gang Yu
-
Agilent Technologies Reports Third Quarter Fiscal Year 2019 Financial Results
-
Agilent Settles Key Intellectual Property Case in China
-
Agilent Technologies (A) Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma
-
Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC)
-
Agilent Technologies to Host Webcast of Third-Quarter Fiscal Year 2019 Financial Results Conference Call
-
Agilent Technologies (A) to Acquire BioTek in $1.17 Billion Deal
-
Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment
-
Agilent Introduces Breakthrough Flow Cytometer
-
New State of the Art Facility Increases Agilent’s Capacity to Produce Nucleic Acid-Based Therapeutics
-
Agilent Technologies (A) Companion Diagnotic PD-L1 IHC 22C3 pharmDx Assay Granted Expanded FDA Approval for HNSCC
-
Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)
-
Agilent Technologies Announces Webcasts for Investment Community
-
Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies
-
Agilent Introduces Intelligent LC/MS System for Chromatographers at ASMS 2019
-
Agilent Showcases Mass Spec Solutions at ASMS 2019
-
Agilent Technologies Reports Second Quarter Fiscal Year 2019 Financial Results
-
Agilent Announces Unique Portfolio to Advance Immunotherapy
-
Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays
-
Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC
-
ACEA Biosciences – A Part of Agilent Launches the xCELLigence RTCA ePacer to improve the Quality and Functionality of hiPSC-Cardiomyocytes for Drug Discovery, Safety Pharmacology, and Cardiac Diseas
-
Agilent Technologies to Host Webcast of Second-Quarter Fiscal Year 2019 Financial Results Conference Call

